Mustards and Vesicants

Handbook of Toxicology of Chemical Warfare Agents

Volumn , Issue , 2009, Pages 93-108

  Young, Robert A ^a   Bast, Cheryl ^a  

^a OAK RIDGE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79951572666     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374484-5.00008-0     Document Type: Chapter

References (120)

1. Anderson, J.S. (1942). The effect of mustard gas vapour on eyes under Indian hot weather conditions. CDRE Report No. 241. Chemical Defense Research Establishment (India).
2. Armstrong, G.C. (1923). The toxicity of M-1 by inhalation for dogs. Chapter II. In The toxicity, pathology, chemistry, mode of action, penetration, and treatment for M-1 and its mixtures with arsenic trichloride. Part 1. Edgewood Arsenal, Aberdeen Proving Ground, MD, August 13, 1923. ADB954935. Unclassified Report/Limited Distribution.
3. ATSDR (Agency for Toxic Substances and Disease Registry) (2003). Toxicological profile for sulfur mustard. Agency for Toxic Substances and Disease Registry, Atlanta, GA. Available at. http://www.atsdr.cdc.gov.
4. Axelrod D.J., Hamilton J.G. Radio-autographic studies of the distribution of lewisite and mustard gas in skin and eye tissues. Am. J. Pathol 1947, 23:389-411.
5. Boursnell J.C., Cohen J.A., Dixen M., et al. Studies on mustard gas (2,20-dichlorodiethyl sulphide) and some related compounds. 5. The fate of injected mustard gas (containing radioactive sulphur) in the animal body. Biochem. J 1946, 40:756-764.
6. Bowden, E. (1943). Median detectable concentrations by odor of plant run mustard, plant run Lewisite and pilot plant ethyl nitrogen mustard. ADB 969801, TDMR 615 (April).
7. Brimfield A.A., Hodgson E. Observations on the interaction of sulfur mustard with cytochrome P450. Toxicologist 2005, 84(S-1):159.
8. Brimfield A.A., Novak M.J., Mancebo A.M., Gallagher B.S., Arroyo M. The detection of free radical formation from the interaction of sulfur mustard with NADPH-cytochrome P450 reductase. Toxicologist 2006, 90:391.
9. The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals 1989, Merck and Co., Rahway, NJ. 11th edition. S. Budavari, M.J. O'Neil, A. Smith, P.R. Heckelman (Eds.).
10. Buxton K.L., Babin M.C., Ricketts K.M., Gazaway M.Y., Blank J.A., Danne M.M. Characterization of sulfur mustard-induced proinflammatory mediator response in mouse ears. Toxicologist 2000, 54:213.
11. Buxton K.L., Danne M.M., Babin M.C., Ricketts K.M., Gazaway M.Y., Sabourin C.L., Casillas R.P., Schlager J.J. Gene array analysis of sulfur mustard-induced inflammatory mediator response in mouse ear. Toxicologist 2001, 60:129.
12. Cameron G.R., Carleton H.M., Short R.H.D. Pathological changes induced by Lewisite and allied compounds. J. Pathol. Bacteriol 1946, 58:411-422.
13. Clark, D.N. (1989). Review of reactions of chemical agents in water. AD-A213 287, Defense Technical Information Center.
14. Clark O.E., Neally E.W., Leiter K.W., Finke K.I., Miller A.L., Smith W.J. Putative role of platelet activating factor (PAF) analogs in cell cycle aberrations in human endothelial cells. in vitro. Toxicologist 2005, 84(S-1):160.
15. Clark O.E., Neally E.W., Leiter K., Miller A.L., Nicholson J.D., Smith W.J. Endothelial cell alterations following in vitro exposure to sulfur mustard or platelet activating factor. Toxicologist 2006, 90:391.
16. Clemedson C.J., Kristofferson H., Sorbo B., et al. Whole body autoradiographic studies of the distribution of sulphur 35-labelled mustard gas in mice. Acta Radiol. Ther. Phys. Biol. 1963, 1:314-320.
17. DA (US Department of the Army) (1974). Chemical agent data sheets. Vol. 1. Tech. Report E-SR-74001, Edgewood Arsenal Special Report, US Department of the Army, Defense Technical Information Center, Alexandria, VA.
18. DA (US Department of the Army) (1996). Detailed and General Facts About Chemical Agents -TG 218. US Army Center for Health Promotion and Preventive Medicine, Aberdeen Proving Ground, MD.
19. DA (US Department of the Army) (1997). The Army Chemical Agent Safety Program. Army Regulation AR 385-61. Headquarters, Department of the Army, Washington, DC.
20. Dacre J.C., Goldman M. Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacol. Rev. 1996, 48:289-326.
21. Danforth C.H., Center E. Nitrogen mustard as a teratogenic agent in the mouse. Proc. Soc. Exp. Biol. Med 1954, 86:705-707.
22. Danne M.M., Babin M.C., Gazaway M.Y., Ricketts K.M., Schlager J.J., Buxton K.L. Gene expression array analysis of sulfur mustard-induced proinflammatory mediator response in mouse ears. Toxicologist 2000, 54:213.
23. Davison C., Rozman R.S., Smith P.K. Metabolism of bis(2-chloroethyl) sulfide (sulfur mustard gas). Biochem. Pharmacol 1961, 7:65-74.
24. DHHS (US Department of Health and Human Services) Final recommendations for protecting the health and safety against potential adverse effects of long-term exposure to low doses of agents: GA, GB, VX, mustard agent (H, HD, HT), and lewisite (L). US Department of Health and Human Services, Centers for Disease Control. Fed. Reg 1988, 53(50):8504-8507.
25. Dudley H.C., Wells W.J.H.B. The detection of HS by odor. ADB 959500, EATR 249 (March 1936) (as cited in personal communication from S. Reutter, US Army Edgewood Research Development and Engineering Center 1938, APG, MD, October 1995.
26. Eisenmenger W., Drasch G., von Clarmann M., Kretschmer E., Roider G. Clinical and morphological findings on mustard gas [bis(2-chloroethyl)sulfide] poisoning. J. Forensic Sci. 1991, 36:1688-1698.
27. Eldridge, W.A. (1923). Blistering concentrations of M-1 vapors for exposures from five minutes to three hours. Chapter IV. In The toxicity, pathology, chemistry, mode of action, penetration, and treatment for M-1 and its mixtures with arsenic trichloride. Part 1. Edgewood Arsenal, Aberdeen Proving Ground, MD. August 13, 1923. ADB954935. Unclassified Report/Limited Distribution.
28. Elsayed N., Omaye S. Pulmonary biochemical alterations induced by systemic administration of nitrogen mustard. Toxicologist 2006, 90:392.
29. Epstein J. Nerve gas in public water. Public Health Rep. 1956, 71:955-962.
30. Ferguson R.L., Silver S.D. method for the visual demonstration of Lewisite in skin. Am. J. Clin. Pathol 1947, 17:37-38. A.
31. Fox M., Scott D. The genetic toxicology of nitrogen and sulfur mustard. Mutat. Res. 1980, 75:131-168.
32. Franke, S. (1977). Textbook of Military Chemistry, Vol. I, 2nd revised edition. Military Publisher of the German Democratic Republic, Berlin. Translation. Department of the Army, US Army Medical Intelligence and Information Agency, Fort Detrick, Frederick, MD. Unclassified Report/Limited Distribution.
33. Fuhr, I., Krakow, E.H. (1945). Median lethal concentrations of H for mice and rats. For various exposure times. MDR 21, March 21 (as cited in McNamara et al., 1975).
34. Gates, M., Williams, J.W., Zapp, J.A. (1946). Arsenicals (Chapter 7). In NDRC (National Defense Research Committee), Chemical Warfare Agents and Related Chemical Problems, Vol. I, Parts I-VI. Summary Technical Report of Division 9, NRDC. Office of Scientific Research and Development, National Defense Research Committee. US Department of Commerce National Technical Information Service. PB158507 and PB158508.
35. Gerecke D.R., Bhatt P., Chang Y., et al. The matrix metalloproteinase inhibitor GM 1489 reduces MMp-9 activity after sulfur mustard exposure. in vivo. Toxicologist 2005, 84(S-1):451.
36. Goldman M., Dacre J.C. Lewisite: its chemistry, toxicology, and biological effects. Rev. Environ. Contam. Toxicol 1989, 110:76-115.
37. Gordon R., Baker K., Askins L., Ratcliffe R., Lindsay D., Owens R., et al. Chemical warfare agents (organophosphates and vesicant) and biological decontamination and detoxification using polyurethane sponges. Toxicologist 2006, 90:393.
38. Gray, P.J. (1989). A literature review on the mechanism of action of sulphur and nitrogen mustard. MRL Tech. Report MRL-TR-89-24. DSTO Materials Research Laboratory, Victoria, Australia.
39. Guild W.J., Harrison K.P., Fairly A., Childs A.E. (1941). The effect of mustard gas vapour on the eyes. Porton Report No. 2297, Serial No. November 8, 1941, 12.
40. Hackett P.L., Rommereim R.L., Burton F.G., Buschbom R.L., Sasser L.B. Teratology studies on Lewisite and sulfur mustard agents: Effects of sulfur mustard in rats and rabbits. Final Report. AD A187495. Pacific Northwest Laboratory, Richland, WA 1987, for the US Army Medical Research and Development Command, Fort Detrick, MD.
41. 35S-sulphur mustard in rat and comparison with human blood in vitro. Xenobiotica 1993, 23:537-561.
42. Hardej D., Billack B. Reduction of mechlorethamine cytotoxicity by ebselen in normal and tumor-derived cell lines. Toxicologist 2006, 90:391.
43. Haskin D. Some effects of nitrogen mustards on the development of the external body form in the fetal rat. Anat. Rec. 1948, 102:493-511.
44. Heston W.E. Carcinogenic action of mustards. J. Natl Cancer Inst 1950, 11:415-423.
45. Heston W.E. Occurrence of tumors in mice injected subcutaneously with sulfur mustard and nitrogen mustard. J. Natl Cancer Inst 1953, 14:131-140.
46. HSDB (Hazardous Substances Data Bank) (2004) Retrieved online. Lewisite. National Library of Medicine March 15, 2004, National Institutes of Health.
47. Hurst C.G., Smith W.J. Health effects of exposure to vesicant agents. Chemical Warfare Agents, Chemistry, Pharmacology, Toxicology, and Therapeutics 2008, 293-312. CRC Press, Boca Raton, FL. J. Romano, B. Lukey, H. Salem (Eds.).
48. IARC (International Agency for Research on Cancer) (1975). IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Man: Some Aziridines, N, S, & O-Mustards and Selenium, Vol. 9, pp. 181-207. International Agency for Research on Cancer, Lyons, France.
49. IARC (International Agency for Research on Cancer) International Agency for Research on Cancer, Lyons, France. IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Man: Overall Evaluation of Carcinogenicity: An Updating of IARC Monographs 1987, Vols. 1-42:67. Suppl. 7259-60 and 398.
50. Inada S., Hiragun K., Seo K., Yamura T. Multiple Bowen's disease observed in former workers of a poison gas factory in Japan, with special reference to mustard gas exposure. J. Dermatol 1978, 5:49-60.
51. IOM (Institute of Medicine, Committee to Survey the Health Effects of Mustard Gas and Lewisite, Division of Health Promotion and Disease Prevention) Veterans at Risk; The Health Effects of Mustard Gas and Lewisite 1993, National Academy Press, Washington, DC. C.M. Pechura, D.P. Rall (Eds.).Health Promotion and Disease Prevention)
52. Medical Response to Terrorism 2005, Lippincott Williams & Wilkins, Philadelphia, PA. D.C. Keyes, J.L. Burstein, R.B. Schwartz, R.E. Swienton (Eds.).
53. Krause H., Grussendorf E.I. Syntopy of Bowen's disease and Lewisite scar. Hautarzt 1978, 29:490-493.
54. Langenberg J.P., van der Schans G.P., Spruit H.E.T., et al. Toxicokinetics of sulfur mustard and its DNA-adducts in the hairless guinea pig. Drug Chem. Toxicol. 21. Suppl. 1998, 1):131-147.
55. Lindberg, G., Runn, P., Winter, S., Fallman, A. (1997). Basic information on lewisite -a chemical warfare agent with effects similar to mustard gas. Defense Research Establishment, Division of NBC Defense, Umeå, Sweden.
56. McNamara, B.P., Owens, E.J., Christensen, M.K., Vocci, F.J., Ford, D.F., Rozimarek, H. (1975). Toxicological basis for controlling levels of mustard in the environment. EASP EBSP 74030. Biomedical Laboratory, Department of the Army, Headquarters, Edgewood Arsenal, Aberdeen Proving Ground, MD.
57. MacNaughton M.G., Brewer J.H. Environmental Chemistry and Fate of Chemical Warfare Agents. SWRI Project 01-5864 1994, Southwest Research Institute, San Antonio, TX.
58. Mancheco A.M., Brimfield A.A. Interaction of sulfur mustard with NADPH-cytochrome P450 reductase and cytochrome P450 isoforms. Toxicologist 2006, 90:391.
59. Miccadei S., Kyle M.E., Gilfor D., Farber J.L. Toxic consequences of the abrupt depletion of glutathione in cultured rat hepatocytes. Arch. Biochem. Biophys 1988, 265:311-320.
60. Morrill L.G., Reed L.W., Chinn K.S.K. Interaction of some toxic chemicals/chemical warfare agents and soils. Toxic chemicals in the soil environment 1985, Vol. 2. Oklahoma State University TECOM Project 2-CO-210-049, Stillwater, OK, Available fromDTIC, AD-A158 215.
61. Murphy M.L., Del Moro A., Lacon C. The comparative effects of five polyfunctional alkylating agents on the rat fetus, with additional notes on the chick embryo. Ann. NY Acad. Sci. 1958, 68:762-782.
62. Munro N.B., Watson A.P., Ambrose K.R., Griffin G.D. Treating exposure to chemical warfare agents: implications for health care providers and community emergency planning. Environ. Health Perspect 1990, 89:205-215.
63. NDRC (National Defense Research Committee) (1944). Geiling, E.M.K., Cannan, R.K., Bloom, W. Toxicity of chemical warfare agents. NDRC-IMPR-9-4-1-17. June 1944.
64. NDRC (National Defense Research Committee) (1945) The penetration of vesicant vapors into human skin. Rockefeller Inst March 24, 1945, Med. Res. OSRD Report No. 4855.
65. NDRC (National Defense Research Committee) Summary Technical Report of Division 9, NDRC. Office of Scientific Research and Development, National Defense Research Committee. US Department of Commerce National Technical Information Service. PB158507 and PB158508. Chemical warfare agents and related chemical problems 1946, Vol. I. Parts I-VI.
66. NRC (National Research Council) Review of the U.S. Army's Health Risk Assessments for Oral Exposure to Six Chemical Warfare Agents. Subcommittee on Chronic Reference Doses for Selected Chemical-Warfare Agents, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission on Life Sciences. National Research Council 1999, National Academy Press, Washington, DC.
67. NRC (National Research Council) Acute Exposure Guideline Levels for Selected Airborne Chemicals. Subcommittee on Chronic Reference Doses for Selected Chemical-Warfare Agents, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission on Life Sciences. National Research Council 2003, National Academy Press, Washington, DC.
68. Papirmeister B., Feister A.J., Robinson S.I., Ford R.D. Medical Defense Against Mustard Gas: Toxic Mechanisms and Pharmacological Implications 1991, CRC Press, Boca Raton, FL.
69. Perera J. Lewisite: new gas weapon in Gulf war. New Scientist 1985, 105:8.
70. Peters R.A., Stocken L.A., Thompson R.H.S. British anti-lewisite. Nature (London) 1945, 156:616.
71. Porton Report (1942a). On the action of S on the eye; its comparison with allied compounds and with H. No. 2402. August 7, 1942. Cited in NDRC (1946).
72. Porton Report (1942b). Pathological changes in animals exposed to S vapour. No. 2378. July 9, 1942. Cited in NDRC (1946).
73. Porton Report (1943a). Vapour toxicity and pathology of ethyl, n-propyl and iso-propyl analogues of HN2. No. 2565. December 10. Cited in NDRC (1946).
74. Porton Report (1943b). Toxicity of S vapour. Further experiments on the exposure of animals to S vapour. No. 2464. February 9, 1943. Cited in NDRC (1946).
75. Porton Report (1943c). Toxicity and pathology of HN3. No. 2548. November 18, 1944. Cited in NDRC, (1946).
76. Porton Report (1943d). The effects of HN1 vapour on human and rabbit eyes. No. 2563. November 18, 1943. Cited in NDRC (1946).
77. Reed, C.I. (1918). The minimum concentration of mustard gas effective for man. Preliminary Report. Report 318. War Department, Med. Div., C.W.S. Pharmacol. Res. Sec. Amer. Univ. Exp. Station, War Dept. October 26, 1918.
78. Reed C.I., Hopkins E.F., Weyand C.F. (1918). The minimum concentration of mustard gas effective for man. Final Report. Report 329. War Department, Med. Div. C.W.S. December 2, 1918, Pharmacol. Res. Sec. Amer. Univ. Exp, Station, War Dept.
79. Renshaw B. Observations on the role of water in the susceptibility of human skin to injury by vesicant vapors. J. Invest. Dermatol 1947, 9:75-85.
80. Riviere J.E., Brooks J.D., Williams P.L., Monteiro-Riviere N.A. Toxicokinetics of topical sulfur mustard penetration, disposition, and vascular toxicity in isolated perfused porcine skin. Toxicol. Appl. Pharmacol. 1995, 135:25-34.
81. Roberts J.J., Warwick G.P. Studies of the mode of action of alkylating agents -VI. The metabolism of bis-b-chloroethylsulfide (mustard gas) and related compounds. Biochem. Pharmacol. 1963, 12:1239-1334.
82. Romano, J.A., Jr., Lukey, B.J., Salem, H. (eds) (2008). Chemical Warfare Agents, Chemistry, Pharmacology, Toxicology, and Therapeutics. CRC Press, Boca Raton, FL.
83. Rosenblatt D.H., Miller T.A., Dacre J.C., Muul I., Cogley D.R. Problem definition studies on potential environmental pollutants. II. Physical, chemical, toxicological, and biological properties of 16 substances. Technical Report 7509, US Army Medical Bioengineering Research and Development Laboratory 1975, Fort Detrick, Frederick, MD.
84. Rosenblatt D.H., Small M.J., Kimmell T.A., Anderson A.W. Agent decontamination chemistry. Technical Report. US Army Test and Evaluation Command (TECOM) Technical report 1995, Phase I. Draft Report, Argonne National Laboratory.
85. Ruth, J.H. (1986). Odor thresholds and irritation levels of several chemical substances: a review. Am. Ind. Hyg. Assoc. J.47: A-142-51.
86. Sasser, L.B., Cushing, J.A., Kalkwarf, D.R., Mellick, P.W., Buschbom, R.L. (1989a). Toxicology studies on Lewisite and sulfur mustard agents: subchronic toxicity study of Lewisite in rats. Final Report, Pacific Northwest Laboratory Report, PNL-6860, Richland, WA.
87. Sasser, L.B., Cushing, J.A., Kalkwarf, D.R., Mellick, P.W., Buschbom, R.L. (1989b). Toxicology studies of Lewisite and sulfur mustard agents: two-generation reproduction study of Lewisite in rats. Final Report, Pacific Northwest Laboratory Report, PNL-6978, Richland, WA.
88. Sasser, L.B., Miller, R.A., Kalkwarf, D.R., Cushing, J.A., Dacre, J.C. (1996a). Subchronic toxicity of sulfur mustard (HD) in rats. J. Appl. Toxicol.16: 5-13.
89. Sasser, L.B., Cushing, J.A., Dacre, J.C. (1996b). Two-generation reproduction study of sulfur mustard in rats. Reprod. Toxicol.10: 311-19.
90. Schier, J.G., Hoffman, R.S. (2005). Equipment preparedness for terrorism. In Medical Response to Terrorism (Keyes, D.C., Burstein, J.L., Schwartz, R.B., Swienton, R.E., eds), pp. 284-92. Lippincott Williams & Wilkins, Philadelphia, PA.
91. Shakil F.A., Kuramoto M., Yamakido M., et al. Cytogenetic abnormalities of hematopoietic tissue in retired workers of the Ohkunojima poison gas factory. Hiroshima J. Med. Sci. 1993, 42:159-165.
92. Sidell F.R., Hurst C.G. Clinical considerations in mustard poisoning. Chemical Warfare Agents 1992, Academic Press, New York. S.M. Somani (Ed.).
93. Silver, S.D., McGrath, F.P. (1943). Lewisite (M-1): the stereoisomers. Investigation of discrepancies between nominal and analytical concentrations; redetermination of LC50 for mice. Chemical Warfare Service, January 29, 1943. AD-B960457L. Unclassified Report/Limited Distribution.
94. Small M.J. Compounds formed from the chemical decontamination of HD, GB, and VX and their environmental fate. US Army Medical Bioengineering Research and Development Laboratory 1984, Fort Detrick, Frederick, MD., Technical Report 8304. ADA 149515.
95. Smith M.G., Stone W., Ren-Feng G., et al. Vesicants and oxidative stress. Chemical Warfare Agents, Chemistry, Pharmacology, Toxicology, and Therapeutics 2008, 293-312. CRC Press, Boca Raton, FL. J. Romano, B. Lukey, H. Salem (Eds.).
96. Snider T.H., Wientjes M.G., Joiner R.I., Fisher G.L. Arsenic distribution in rabbits after lewisite administration and treatment with British anti-lewisite (BAL). Fundam. Appl. Toxicol. 1990, 14:262-272.
97. Sollman, T.H. (1957). Lewisite. In Manual of Pharmacology and its Applications to Therapeutics and Toxicology, 8th edition (T.H. Sollman, ed.), pp. 192-3. W.B. Saunders Co., Philadelphia, PA.
98. Somani S.M. Toxicokinetics and toxciodynamics of mustard. Chemical Warfare Agents 1992, Academic Press, New York. S.M. Somani (Ed.).
99. Somani S.M., Babu S.R. Toxicodynamics of sulfur mustard. Int. J. Clin. Pharmacol. Ther. Toxicol 1989, 27:419-435.
100. Spiers E.M. Chemical Warfare 1968, University of Illinois Press, Champaign, IL.
101. Tanaka Y. the story Japan would like to forget. Bull. Atomic Sci. October 1988, 10-19. Poison gas.
102. Trammell G.L. Toxicodynamics of organoarsenic chemical warfare agents. Chemical Warfare Agents 1992, 255-270. Academic Press, New York. S.M. Somani (Ed.).
103. USACHPPM (US Army Center for Health Promotion and Preventive Medicine) (1996). Detailed and general facts about chemical agents -TG 218. USACHPPM, Aberdeen Proving Ground, MD. USACHPPM TG No. 218. October 1996.
104. USACHPPM(US Army Center for Health Promotion and Preventive Medicine) Derivation of health-based environmental screening levels for chemical warfare agents 1999, a technical evaluation, Aberdeen Proving Ground, MD.
105. USACHPPM (US Army Center for Health Promotion and Preventive Medicine) (2000). Evaluation of airborne exposure limits for sulfur mustard: occupational and general population exposure criteria. Aberdeen Proving Ground, MD. Technical Report 47-EM-3767-00.
106. USACHPPM (US Army Center for Health Promotion and Preventive Medicine) (2004). Acute toxicity estimation and operational risk management of chemical warfare agent exposures. USACHPPM Report No. 47-EM-5863-04. USACHPPM, Aberdeen Proving Ground, MD. May 2004.
107. US Army Medical Division (1945a). Medical Division monthly progress report. March 1945. Cited in NRDC (1946).
108. US Army Medical Division (1945b). Medical Division monthly progress report. February 1945. Cited in NRDC (1946).
109. US EPA (US Environmental Protection Agency) (1984). Health effects assessment for arsenic. Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office. Cincinnati, OH. PB-13319, EPA/540/1-86/120.
110. US EPA (US Environmental Protection Agency) (2008). Arsenic, inorganic (CASRN 744-38-2). Last revised 04/10/1998. Integrated Risk Information System. http://www.epa.gov/iris/0278.htm.
111. Van Vloten W.A., Cooijams A.C.M., Poel J., Meulembelt J. Concentrations of nitrogen mustard in the air during topical treatment of patients with mycosis fungoides. Br. J. Dermatol. 1993, 128:404-406.
112. Vijayaraghavan R. Modifications of breathing pattern induced by inhaled sulphur mustard in mice. Arch. Toxicol 1997, 71:157-164.
113. Vojvodić V., Milosavljević Z., Bosković B., Bojanić N. The protective effect of different drugs in rats poisoned by sulfur and nitrogen mustards. Fundam. Appl. Toxicol 1985, 198:S160-S168.
114. Wada S., Nishimoto Y., Miyanishi M., et al. Mustard gas as a cause of respiratory neoplasm in man. Lancet 1968, 1161-1163. i.
115. Watson A.P., Griffin G.D. Toxicity of vesicant agents scheduled for destruction by the chemical stockpile disposal program. Environ. Health Perspect 1992, 98:259-280.
116. Watson A.P., Jones T.D., Griffin G.D. Sulfur mustard as a carcinogen: application of relative potency analysis to the chemical warfare agents H, HD, and HT. Reg. Toxicol. Pharmacol 1989, 10:1-25.
117. Wils E.R.J. Analysis of thiodiglycol in urine of victims of an alleged attack with mustard gas. Part II. Prins Mauritis Laboratorium, Institute for Chemical and Technological Research 1987, PML, The Netherlands, 1987-31.
118. Yamakido M., Nishimoto Y., Shigenobu T., Onari K., Satoh C., Goriki K., Fujita M. Study of genetic effects of sulphur mustard gas on former workers of Okunojima poison gas factory and their offspring. Hiroshima J. Med. Sci. 1985, 34:311-322.
119. Young, L., McCarter, J.A., Edson, M., Estok, E. (1944). Biochemical experiments with mustard gas prepared from radioactive sulphur. V. The systemic distribution of S35 at different times after application of radioactive mustard gas to the skin of the rat. University of Toronto, Canada, Report No. 17, C.P. 75.
120. Young R.A. Health Risk Assessment for Lewisite. In Health Risk Assessments for Oral Exposure to Six Chemical-Warfare Agents. National Research Council 1999, National Academy Press, Washington, DC.